QP-Prostate®

Your advanced solution for prostate MRI based on Artificial Intelligence for automated prostate segmentation and lesion detection*.

Book a demo

Discover QP-Prostate®
images_prostate_3d_3

Prostate cancer is the second most common  cancer in men, representing a significant public health concern. While MRI scans are essential for early detection, the growing demand has surpassed the availability of radiology experts, with diagnostic delays and inconsistencies in interpretation as direct consequences. Only a minority of the medical community consistently follows PI-RADS v2.1 guidelines.

 

Book a demo

Prostate segmentation & lesion detection

QP-Prostate’s AI algorithm achieves 88% accuracy in segmenting the prostate gland and seminal vesicles, highlighting High (orange) and Moderate (yellow) risk areas for clinically significant prostate cancer (csPCa). This precision supports PSA density calculations and fusion biopsy planning. Our advanced AI-driven lesion detection, utilizing biparametric input (T2W and DWI), efficiently identifies prostate cancer lesions, setting a new standard for accuracy, speed, and diagnostic precision.

qp-prostate_seg_det_v6

 

Download the QP-Prostate Brochure

QP-Prostate: a set of enhanced diagnostic capabilities

  • AI-based automatic lesion detection*

    Our AI algorithm, trained with pathology outcomes as ground truth, is designed to efficiently detect clinically significant prostate cancer lesions using biparametric inputs (T2w, DWI and ADC), outperforming competitors in detection rate and speed. These AI algorithms are intended to elevate radiologists’ diagnostic accuracy with automated detection of biopsy-proven, clinically significant prostate cancer lesions.

  • Precision in segmentation

    QP-Prostate’s AI algorithm automatically identifies the prostate anatomy and segments the full prostate gland with market-leading performance (88% DSC1), as well as the seminal vesicles, to assist in PSA density calculations. The results can be directly exported for fusion biopsy procedures.

  • Quantitative analysis

    QP-Prostate automatically verifies MRI acquisition protocol according to PI-RADSv2.1 guidelines, ensuring that radiologists work with high-quality MRI examinations from the start.

    The platform provides spatially registered, motion corrected, synthesized b-1400s/mm2 DWI and ADC map series, offering rich quantitative diffusion information. This dataset empowers radiologists to analyze potentially cancerous lesions with confidence.  For mpMRI studies, perfusion analysis (Ktrans, Kep, Ve maps) are automatically generated.

  • Cloud to PACS integration

    All analysis outputs are directly sent back to the hospital PACS for their visualization without disrupting radiology workflows.

How does it work?

Efficient workflow, increased confidence.
quibim-diagram-prostate

Clinical cases using QP-Prostate

Case 1

Patient history:
66 years old male, with elevated history of prostate specific antigen (PSA)

Summary:

case1_s2

Case 2

Patient history:
Abnormal prostate exam nodule superior half of right prostate; firm. PSA of 31.3 ng/ml.

Summary:

case2_s2

Case 3

Patient history:
61 years old man with elevated PSA, benign prostatic hyperplasia with lower urinary tract symptoms; PSA of 8.63 ng/mL.

Summary:

case3_s3

Case 4

Patient history:
62 year old male with history of low-grade prostate cancer diagnosed with biopsy. Most recent PSA of 13.34 ng/mL increased compared to prior which measures 9.99 ng/mL.

Summary:

case4_s3

 

Changing the narrative in prostate diagnosis thanks to maximum accuracy in prostate MRI interpretation

In short, QP-Prostate leverages advanced artificial intelligence image processing techniques to offer a state-of-the-art approach to prostate MRI interpretation. This image processing software is compatible with standard workstations and allows for the visualization and analysis of DICOM data by qualified professionals.

Developed by Quibim, QP-Prostate excels in automating the segmentation of critical prostate regions, including the transition zone, peripheral zone and seminal vesicles. By streamlining these complex processes, the software not only aids in the interpretation of prostate MRI images, but also enables more accurate diagnoses. This combination of sophisticated AI-based analysis and user-friendly implementation makes QP-Prostate an invaluable tool in the hands of healthcare professionals, ensuring better patient outcomes through more reliable and detailed assessments.

References

  • Jimenez-Pastor A, et al.  Eur Radiol. 2023;33(7):5087-5096. 

  • Sánchez Iglesias Á, et al.  Cancers (Basel). 2023;15(16):4163.

 

*In the US: Lesion detection functionality pending 510(k), not available for sale within the United States

**Pilot study conducted in 2023 at Massachussets General Hospital.

Interested on learning more about our products?

Book a demo

Interested on learning more about our products?

Book a demo